Have an interest in staying up with the latest in personalized medicine, as well as a Twitter account?
Then consider following these 20 personalized medicine thought leaders.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
This list is restricted to individually-branded, not company-branded, Twitter accounts. To get in on the best conversation, watch for these hashtags: #personalizedmedicine, #pm101, #genomics and #bioinformatics.
Robert West, @westr, associate professor at SUNY Upstate Medical University
Eric Topol, @EricTopol, Chief Academic Officer at Scripps Health
Dan Vorhaus, @genomicslawyer, attorney with Robinson Bradshaw & Hinson
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Daniel Kraft, @daniel_kraft, executive director of FutureMed
Ruby Galderab, @divabiotech, head of marketing and clinical development for international markets with Affymetrix
Daniel MacArthur, @dgmacarthur, genomics researcher at Massachusetts General Hospital
Leroy Hood, @ISBLeeHood, president and cofounder of the Institute for Systems Biology
Keith Darce, @KeithDarce, public relations manager at Scripps Health
Paul Sonnier, @Paul_Sonnier, head of digital health strategy at Popper & Co.
Bertalan Mesko, @Berci, founder of Webicina.com
Margaret Anderson, @MargaretAinDC, executive director of FasterCures
Bruce Booth, @LifeSciVC, partner at Atlas Ventures
Donna Cryer, @DCPatient, CEO at Cryer Health
Sharon Terry, @sharonfterry, president of Genetic Alliance
Dawei Lin, @iGenomics, bioinformatics core director at the UC Davis Genome Center
Stephen Turner, @genetics_blog, bioinformatics core director at the University of Virginia
Joel Dudley, @jdudley, director of informatics at NuMedii
Scott Wagers, @WagersScott, founder of GrantSnap.com
Walter Jessen, @wjjessen, computational biologist, now principal with Walter Jessen Discovery New Media
Jason Moore, @moorejh, director of the Institute for Quantitative Biomedical Sciences at Dartmouth College
[Photo from flickr user SeattleClouds.com]